Global surveillance by the World Health Organization and CDC shows no novel pathogen driving sustained human-to-human transmission at pandemic levels as of October 2026, supporting the 94.5% market-implied odds against a new pandemic this year. Routine monitoring of influenza, coronaviruses, and other respiratory viruses reveals case counts and genomic data consistent with seasonal or endemic patterns rather than explosive outbreaks, with no official public health emergency of international concern declared. Historical precedents like the 2009 H1N1 or early COVID-19 phases highlight how quickly thresholds can be crossed, yet current epidemiological indicators and low zoonotic spillover signals reinforce trader consensus. A sudden emergence of a highly transmissible strain with immune escape or increased virulence could still alter trajectories before year-end.